Letter by Hifumi et al regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin"

Circulation. 2014 Sep 2;130(10):e94. doi: 10.1161/CIRCULATIONAHA.113.008378.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Hemorrhage / therapy*
  • Humans
  • Male
  • Venous Thromboembolism / drug therapy*
  • Warfarin / adverse effects*
  • beta-Alanine / analogs & derivatives*

Substances

  • Benzimidazoles
  • beta-Alanine
  • Warfarin